Seed Round

A North Carolina startup claims a massive efficiency leap in Direct Air Capture, putting the sub-$100/ton 'holy grail' of carbon removal within reach.

As AI reshapes medicine, one veterinary firm's 'No AI' policy is earning major awards and the loyalty of the vets it serves. Here's why.

Dr. Pietro Garbelli's award-winning book offers a crucial roadmap for responsibly integrating AI, balancing high-tech innovation with patient trust.

A new drug for Raynaud's phenomenon in scleroderma patients significantly boosts attack-free days, offering hope despite missing its primary trial goal.

Fueled by strong investor demand and a lead order from Purpose Global Resource Fund, Lithium Africa will acquire a key South African lithium asset.

With FDA Breakthrough status for its MASH drug, a new CEO, and a fortified balance sheet, Altimmune is poised to take on serious liver disease and addiction.

A new strategic partnership between AlbaCore and MUFG aims to unlock billions for UK and European infrastructure, offering investors access to stable returns.

Phoenix innovator GACW proves its steel Air Suspension Wheel in brutal -40°F mining tests, paving the way for a safer, non-pneumatic 2026 commercial release.

Entrepreneur Daniel Gestetner discusses resilience, a $1B exit, and why true success isn't about winning at all costs in a revealing new podcast.

HYCU earns its sixth straight CRN 5-Star award, signaling market dominance through its partner-first strategy and expansive R-Cloud SaaS support.

Argo Biopharma's new CFO/CSO, Dr. Gena Wang, leaves a star analyst career at Barclays, signaling a major validation for the company's siRNA platform.

Born from a Novartis mega-deal, Atrium Therapeutics aims its novel RNA platform at rare, untreatable genetic heart diseases. Will its strategy succeed?

With 10 million users acquired organically, Presentations.AI is leading a shift from static slides to dynamic, AI-powered 'decision infrastructure'.

A new partnership aims to equip India's 63 million SMBs with AI agents that can autonomously transact, potentially sparking a new economic revolution.

Y Combinator-backed Coinrule now offers AI-driven trading for stocks and ETFs, entering a competitive market under the watchful eye of regulators.

With its CFO at a key forum, Syntiant leverages 100M+ chip deployments to prove the value of on-device intelligence in a booming multi-billion dollar market.

A nonprofit is investing millions in a novel program to fast-track academic breakthroughs for neurological diseases from the lab to patients.

A new AI platform, Alti, claims to boost productivity and retention by creating a 'digital twin' to optimize employee well-being. But can it deliver?

From the founders of thinkorswim, a new AI platform claims you're underpaid by millions and offers tools to prove it. Here's how Lossdog works.

A new self-serve platform offers on-demand NVIDIA and AMD systems locally, providing an alternative to cloud costs and lock-in for AI and VFX industries.